In the present study, we quantified mRNA expression levels of KLK10 and KLK11 in a well-defined cohort of patients afflicted with triple-negative breast cancer, and evaluated their potential as prognostic factors. The gene discussed is KLK10; the disease is triple-negative breast carcinoma.